Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
Koh
Kwang Kon
KK
Department of Cardiology, Gil Heart Center, Gachon Medical School, Incheon, Korea. kwangk@gilhospital.com
Quon
Michael J
MJ
Lee
Sang Jin
SJ
Han
Seung Hwan
SH
Ahn
Jeong Yeal
JY
Kim
Jeong-a
JA
Chung
Wook-Jin
WJ
Lee
Yonghee
Y
Shin
Eak Kyun
EK
D052242:Adiponectin / Q000097:blood; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000097:blood; D004095:Dihydropyridines / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D020738:Leptin / Q000097:blood; D009596:Nitrophenols / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010919:Placebos; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology
D052242:Adiponectin; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D008076:Cholesterol, HDL; D004095:Dihydropyridines; D020738:Leptin; D009596:Nitrophenols; D009943:Organophosphorus Compounds; D010919:Placebos; C066425:efonidipine